The purpose of this study was to compare the efficacy and safety of ce
tirizine, 10 mg, once daily in the morning to terfenadine, 60 mg, BID
in the treatment of seasonal allergic rhinitis. The multicenter, singl
e-blind, parallel study involved 160 patients, who were all included i
n the safety and efficacy analysis. The results of the study showed th
at both cetirizine, 10 mg, QD and terfenadine, 60 mg, BID used for 1 w
eek are safe and effective in the management of allergic rhinitis. By
repeated measures analysis, cetirizine improved symptoms more than ter
fenadine for the treatment period of days four to seven. Standard Coch
ran-Mantel-Haenszel statistics test showed the relative degree of pati
ent satisfaction to he higher in the cetirizine group.